版本:
中国

BRIEF-Abeona Therapeutics provides update on EB-101 gene therapy

May 2 Abeona Therapeutics Inc

* Abeona Therapeutics provides update on EB-101 gene therapy for severe form of epidermolysis bullosa from the society for investigative dermatology conference

* EB-101 demonstrates significant wound healing in 100 pct of treated wounds at 3 months; 89 pct at 6 months, 83 pct at 12 months Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐